Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection.

Shinkai, Noboru; Tanaka, Yasuhiro; Orito, Etsuro; Ito, Kiyoaki; Ohno, Tomoyoshi; Hirashima, Noboru; Hasegawa, Izumi; Sugauchi, Fuminaka; Ueda, Ryuzo; Mizokami, Masashi

Shinkai, Noboru; Tanaka, Yasuhiro; Orito, Etsuro; Ito, Kiyoaki; Ohno, Tomoyoshi; Hirashima, Noboru; Hasegawa, Izumi; Sugauchi, Fuminaka; Ueda, Ryuzo; Mizokami, Masashi.

Shinkai N; Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Hepatol Res ; 36(4): 272-6, 2006 Dec.

Article en En | MEDLINE | ID: mdl-16971173

Search on Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2006 Tipo del documento: Article

Search on Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2006 Tipo del documento: Article